Keyword Connections

her2

Journals

3

1 European journal of medicinal chemistry

2 International journal of molecular sciences

3 the journal of pathology

Research Groups

0

No Research Group Connected

Bibliographies

17

1 The Pattern of Signatures in Gastric Cancer Prognosis.

2 Integrated genomic and transcriptomic analysis of human brain metastases identifies alterations of potential clinical significance.

3 clinical utility of her2 assessed by immunohistochemistry in patients undergoing curative resection for gastric cancer

4 tailoring dna vaccines: designing strategies against her2 positive cancers

5 the coexpression and prognostic significance of c-met, fibroblast growth factor receptor 2, and human epidermal growth factor receptor 2 in resected gastric cancer: a retrospective study

6 immunohistochemical assessment of her2 expression in gastric cancer in a cohort of 118 brazilian patients

7 association between cln3 (neuronal ceroid lipofuscinosis, cln3 type) gene expression and clinical characteristics of breast cancer patients

8 liquid biopsy prevents inaccurate her2 status determination by in situ hybridization in a patient with invasive ductal adenocarcinoma of the breast: case report

9 structure based antibody-like peptidomimetics

10 improved aptamers for the diagnosis and potential treatment of her2-positive cancer

11 response to her2 inhibition in a patient with brain metastasis with egfr tki acquired resistance and an her2 amplification

12 omics and immunologic approaches to optimizing cure rates in her2-positive breast carcinomas.

13 pre-clinical assessment of 177lu-labeled trastuzumab targeting her2 for treatment and management of cancer patients with disseminated intraperitoneal disease

14 First-in-human phase 1 study of margetuximab (MGAH22), an Fc-modified chimeric monoclonal antibody, in patients with HER2-positive advanced solid tumors

15 Estrogen receptor-positive breast cancer in Japanese women: trends in incidence, characteristics, and prognosis

16 Author Correction: The prognostic impact of Her2 status in early triple negative breast cancer: a Turkish Oncology Group (TOG) study

17 The prognostic impact of Her2 status in early triple negative breast cancer: a Turkish Oncology Group (TOG) study